Vidaza and pulmonary embolism Patient Reports February 10, 2010

Vidaza Side Effects Report #6010124-3
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 11, 2008. Female patient, weighting 125.0 lb, was diagnosed with ovarian cancer, pulmonary embolism  and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal sepsis, neutropenia, pulmonary embolism . Vidaza dosage: unknown. During the same period patient was treated with VALPROIC ACID, VALPROIC ACID, CARBOPLATIN, CARAFATE, COLACE, DULCOLAX, HYDROCORTISONE, LOVENOX. Patient was hospitalized. Patient died on 11/10/2008.

Vidaza Side Effects Report #6064849-4
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2009. Female patient, weighting 125.0 lb, was diagnosed with ovarian cancer, pulmonary embolism  and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal sepsis, neutropenia, pulmonary embolism . Vidaza dosage: unknown. During the same period patient was treated with VALPROIC ACID, VALPROIC ACID, CARBOPLATIN, CARAFATE, COLACE, DULCOLAX, HYDROCORTISONE, LOVENOX. Patient was hospitalized. Patient died on 11/10/2008.

Vidaza Side Effects Report #4865683-0
Vidaza side effect was reported by a Physician from UNITED STATES on Dec 12, 2005. Female patient, 78 years of age, weighting 235.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: pulmonary embolism . Vidaza dosage: 75 MG/M2 (170 MG, DAILY), SUBCUTANEOUS. During the same period patient was treated with ACYCLOVIR, CIPROFLOXACIN. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5738425-4
Vidaza side effect was reported by a Physician from UNITED STATES on Apr 30, 2008. Male patient, 75 years of age, weighting 218.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: cardiac failure congestive, disease progression, hilar lymphadenopathy, lymphadenopathy mediastinal, pharyngitis streptococcal, prothrombin time prolonged, pulmonary embolism . Vidaza dosage: 75 MG/M2, DAILY X 5,SUBCUTANEOUS. During the same period patient was treated with OXYCODONE, CARTIA XT, HYDRALAZINE, ANAGRELIDE, LASIX, COUMADIN, POTASSIUM, VITAMIN B12. Patient was hospitalized. Patient recovered.


Vidaza Side Effects Report #5524786-8
Vidaza side effect was reported by a Physician from UNITED KINGDOM on Nov 01, 2007. Male patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: pulmonary embolism . Vidaza dosage: (156 MG), SUBCUTANEOUS. During the same period patient was treated with ATENOLOL, FOLIC ACID, PYRIDOXINE, BENDROFLUMETHIAZIDE, FLUOXETINE, TRAMADOL, MESALAMINE, RANITIDINE. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5534154-0
Vidaza side effect was reported by a Physician from UNITED KINGDOM on Nov 15, 2007. Male patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood fibrinogen increased, international normalised ratio decreased, pulmonary embolism . Vidaza dosage: (156 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with ATENOLOL, FOLIC ACID, PYRIDOXINE, BENDROFLUMETHIAZIDE, FLUOXETINE, TRAMADOL, MESALAMINE, RANITIDINE. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5578214-7
Vidaza side effect was reported by a Physician from UNITED KINGDOM on Dec 19, 2007. Male patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood fibrinogen increased, platelet count decreased, pulmonary embolism . Vidaza dosage: 156 MG, DAILY X 7 DAYS, SUBCUTANEOUS. During the same period patient was treated with ATENOLOL, FOLIC ACID, PYRIDOXINE, BENDOFLUMETHIAZIDE, FLUOXETINE, TRAMADOL, MESALAMINE, RANITIDINE. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5241458-8
Vidaza side effect was reported by a Physician from UNITED STATES on Jan 26, 2007. Female patient, 47 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: fungal infection , lung neoplasm, pulmonary embolism . Vidaza dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS. Patient recovered.

Vidaza Side Effects Report #5293978-8
Vidaza side effect was reported by a Physician from UNITED STATES on Mar 23, 2007. Female patient, 47 years of age, weighting 135.4 lb, was diagnosed with myelodysplastic syndrome, decreased appetite and was treated with Vidaza. After drug was administered, patient experienced the following side effects: decreased appetite, fungal infection , hepatic infection, lung neoplasm, pulmonary embolism . Vidaza dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with MEGACE, ATIVAN, VFEND, CASPOFUNGIN. Patient recovered.